mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
SP

Sotac Pharmaceuticals Limited

NSE:SOTACSME
UnclassifiedUnclassified
₹90.1
0%1 Oct close
Mkt cap
—
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
AnnualQuarterly
ConsolidatedStandalone

Standalone figures · ₹ crore

₹ CrMar 2025Mar 2026
6272
COGS4450
Gross profit1822
1113
Operating profit (EBITDA)89
OPM %12.3%12.7%
Depreciation23
Interest12
22
Profit before tax67
Tax22
Tax %25.6%29.1%
55
PAT margin %7.7%6.8%
EPS (₹)4.34.5

₹ CrMar 2025Mar 2026
Equity capital——
Reserves——
Borrowings——
8595
Total equity & liabilities8595
Fixed assets1717
CWIP——
Investments1312
5566
Total assets8595

₹ CrMar 2025Mar 2026
-612
-2-2
8-10
Net cash flow-0-0
Free cash flow-88
CFO / Operating profit %-79.2%133.2%

Compounded sales growth

7 years
—
5 years
—
3 years
—
1 year
15%

Compounded profit growth

7 years
—
5 years
—
3 years
—
1 year
3%

Stock price CAGR

10 years
—
5 years
—
3 years
—
1 year
-21%